Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 5 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Veru Inc | VERU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.32 | 04:04:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.32 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 5 | - | 0.36 - 1.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:24:42 | 5 | $ 1.32 | USD |
Veru Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 193.22M | 146.38M | - | 16.3M | -93.09M | -0.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Veru News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.14 | 1.55 | 1.00 | 1.35 | 3,036,862 | 0.18 | 15.79% |
| 1 Month | 0.69 | 1.92 | 0.67 | 1.32 | 4,193,532 | 0.63 | 91.30% |
| 3 Months | 0.503 | 1.92 | 0.3612 | 0.9665985 | 2,492,869 | 0.817 | 162.43% |
| 6 Months | 0.8414 | 1.92 | 0.36 | 0.8539827 | 1,937,716 | 0.4786 | 56.88% |
| 1 Year | 1.34 | 1.92 | 0.36 | 0.9493502 | 1,588,535 | -0.02 | -1.49% |
| 3 Years | 9.05 | 24.55 | 0.36 | 10.40 | 4,394,084 | -7.73 | -85.41% |
| 5 Years | 1.38 | 24.56 | 0.36 | 10.23 | 3,240,827 | -0.06 | -4.35% |
Veru Description
| Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. |
